Remove Pharma sales reps Remove Physicians Remove Sales
article thumbnail

Pharma’s move to digital Part 1 HCP Marketing

World of DTC Marketing

Of the 75% of physicians who preferred in-person visits from Medtech representatives prior to Covid-19, 47% now prefer virtual exchanges or less-frequent visits. Furthermore, only 10% of physicians had met with a pharmaceutical company representative in a hospital. no pharmaceutical reps). The Challenges for Pharma.

article thumbnail

Mastering Pharmacology: A Game-Changer for Pharma Sales Reps Communicating with HCPs

Pharmaceutical Representative Training

Lacking this fundamental understanding as a sales rep can negatively impact a providers interest in a new product and their business relationship with the company. [1] 1] How can mastering pharmacology give sales reps a competitive advantage when meeting with prospective HCPs?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How to Become a Pharmaceutical Sales Representative

Pharmaceutical Representative Training

What is a pharmaceutical sales representative? Pharmaceutical sales representatives (often times referred to as pharma reps) are hired by pharmaceutical/biotech companies to educate healthcare providers (HCPs) such as physicians, pharmacists, nurses, and physician assistants (PAs) on their company’s product.

article thumbnail

The Value of Humans in a Tech-Driven World

PM360

An Identity Crisis in Pharmaceutical Sales? Today in pharma, people are asking a similar question: In an era of unprecedented technology, is there still value in the human sales rep? There is an irreplaceable value of a human in the sales interaction, centering around something technology cant dogarner trust.

Sales 52
article thumbnail

Veradigm® Digital Health Media Works to Message the Right Physicians at the Right Time

PM360

As pharma reps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks.

article thumbnail

COVID-19: Challenges, Innovation, and What’s Ahead in 2021

Pharma Marketing Network

Mark Bard: I think the most challenging aspect of the current situation is the inability of anyone – patient, physician, payor, or pharma – to truly predict how long it will take for various parts of the system to get to what becomes the steady state – a new way of operating, the new normal. How does the situation impact pharma?

article thumbnail

The Imperative for KAM in Pharma

PM360

Two of ZS’ major studies suggest that the trend towards more advanced KAM strategies and capabilities will continue to accelerate for pharma manufacturers. Furthermore, these studies demonstrate how KAM must be treated not simply as a role or as a sales or market access initiative, but as an organization-wide business strategy.